Novo Nordisk’s Legal Blitz and Discounted Ozempic Copy Signal a New Phase in the GLP-1 Wars
The Danish pharmaceutical giant is firing on multiple fronts — in the courtroom, on the pricing front, and…
TGS Begins First Phase of Major Offshore Seismic Dataset in Equatorial Guinea
Oslo, Norway (10 June, 2026) TGS, a leading provider of energy data and intelligence, today announced the signing of an…
Novo Nordisk’s Sickle Cell Drug Delivers as Buyback Program Advances
Novo Nordisk’s oral sickle cell drug etavopivat met Phase 3 goals, cutting painful crises by 27%. The success…
European Lithium’s Greenland Rare Earths Project Enters New Phase with Leadership Shift
European Lithium’s stake in Critical Metals Corp surges as Greenland approves full project control, appointing a local CEO…
Novo Nordisk’s Buyback and Breakthrough Paint a Complex Picture
Novo Nordisk executes major share buybacks and announces positive Phase 3 results for sickle cell drug etavopivat, pressuring…
Novo Nordisk’s Clinical Win and Competitive Crossroads
Novo Nordisk’s etavopivat meets Phase 3 goals in sickle cell disease, a bright spot as shares fall 23%…
Novo Nordisk’s Clinical Win and Competitive Crossroads
Novo Nordisk’s etavopivat meets Phase 3 goals in sickle cell disease, a bright spot as shares fall 23%…